Latest David A. Ricks News

Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues

Apr. 30, 2024 12:19 PM EDT

Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit. The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street's expectations even as it hustles...